This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: New York University, Other. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012-2017
Title: Innovations by Margaret E Huflejt
Introduction
Margaret E Huflejt is a notable inventor based in La Jolla, California. She has made significant contributions to the field of cancer diagnosis and treatment through her innovative patents. With a total of 2 patents, her work focuses on improving methods for evaluating malignancy status and developing diagnostic systems.
Latest Patents
Huflejt's latest patents include a "System, method and computer-accessible medium for evaluating a malignancy status in at-risk populations and during patient treatment management." This invention, known as ImmunoRuler (IR), provides a visualization system that compares groups of subjects with specific properties, aiding in the assessment of treatment effectiveness. Another significant patent is for "Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes." This invention focuses on the detection and measurement of glycan-protein interactions, particularly in the context of cancer diagnosis and monitoring.
Career Highlights
Throughout her career, Huflejt has worked with prestigious institutions, including New York University. Her research has contributed to advancements in cancer diagnostics and therapeutic strategies.
Collaborations
Huflejt has collaborated with notable professionals in her field, including Marko I Vuskovic and Harvey I Pass. Their combined expertise has furthered the development of innovative solutions in cancer research.
Conclusion
Margaret E Huflejt's contributions to cancer diagnosis and treatment exemplify the impact of innovation in healthcare. Her patents reflect a commitment to improving patient outcomes through advanced diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile